Cite
APA Citation
Bermel, R. A., Waubant, E., Pardo, G., Bass, A., Repovic, P., Newsome, S., Lindsey, J. W., Kile, D., Pradhan, A., Musch, B., & Zabeti, A. (2021). safety evaluation of shorter infusion for ocrelizumab in a substudy of the Phase IIIb CHORDS trial. Annals of clinical and translational neurology, 8(3), 711–715. http://access.bl.uk/ark:/81055/vdc_100123971287.0x000007